Summary of key findings
stroke
STROKE
Waiting time to get the requested medical appointment was a significant driver of preferences. Preference was stronger for control patients probably because they reported a higher average waiting time.The model of pharmacy intervention and integration with primary care also played an important part in decision-making. These preferences were stronger in intervention patients probably because they experienced similar features in the trial.Our results are consistent with international DCE patient enhanced care pharmacy studies where patients express a preference for a shorter waiting time [Results are also consistent with previous research in Portugal where patients express a preference for a shorter waiting time to get a medical appointment [The chance of having a stroke in 5 years did not seem to contribute to decision-making. However, some patients may have not fully understood this attribute.Since we were interested in understanding preferences for public health intervention in a scenario of reimbursement within a tax-financed (public) healthcare system, we framed cost as WTA cost to the NHS, but this may have contributed to an almost null sensitivity.Finally, we sought to estimate the total marginal WTA annual cost to the NHS for the most preferential scenario and the Net Benefit Value. We used the perspective of intervention patients, as argued in previous research [